Lixoft Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $18.6M

Lixoft General Information

Description

Developer of a modeling and simulation platform designed to reduce the cost and increase the success rate of new drug development. The company's platform deals in model-based drug development and advances to the modeling and simulation community in user-friendly tools designed to break the preclinical/ clinical/ vigilance divide for modeling and simulation, enabling drug developers to share information and synthesize them in studies.

Contact Information

Website
www.lixoft.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Discovery Tools (Healthcare)
Parent Company
Primary Office
  • 8 rue de la Renaissance
  • Batiment D
  • 92160 Antony
  • France
+33 09 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lixoft Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Apr-2020 $18.6M 000.00 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2010 Completed Startup
To view Lixoft’s complete valuation and funding history, request access »

Lixoft Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a modeling and simulation platform designed to reduce the cost and increase the success rate of new drug de
Drug Discovery
Antony, France
11 As of 2020
00.00 0000-00-00
000000&0

000000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
00000 00000000000000
Barcelona, Spain
00 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lixoft Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 Corporation Barcelona, Spain 00 0000000000
You’re viewing 1 of 1 competitors. Get the full list »

Lixoft Patents

Lixoft Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4102511-A1 Method for determining an effect of a drug on a patient with a specific dose regimen Pending 11-Jun-2021 000000000 0

Lixoft Executive Team (3)

Name Title Board Seat Contact Info
Jonathan Chauvin Chief Executive Officer
Marc Lavielle Co-Founder, Board Member & Chief Scientist
Jérôme Kalifa Ph.D Co-Founder & Chairman
To view Lixoft’s complete executive team members history, request access »

Lixoft Board Members (2)

Name Representing Role Since
Jérôme Kalifa Ph.D Lixoft Co-Founder & Chairman 000 0000
Marc Lavielle Lixoft Co-Founder, Board Member & Chief Scientist 000 0000
To view Lixoft’s complete board members history, request access »

Lixoft Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lixoft Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
IncubAlliance Accelerator/Incubator Minority 000 0000 000000 0
To view Lixoft’s complete investors history, request access »